ProtoKinetix, Incorporated Stock Other OTC
Equities
PKTX
US7437221002
Biotechnology & Medical Research
Financials (USD)
Sales 2022 | - | Sales 2023 | - | Capitalization | 6.58M |
---|---|---|---|---|---|
Net income 2022 | -1M | Net income 2023 | - | EV / Sales 2022 | - |
Net cash position 2022 | 25.55K | Net cash position 2023 | 20.41K | EV / Sales 2023 | - |
P/E ratio 2022 |
-4.29
x | P/E ratio 2023 |
-1.9
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 60.09% |
Managers | Title | Age | Since |
---|---|---|---|
Clarence Smith
CEO | Chief Executive Officer | 60 | 14-05-31 |
Michael Guzzetta
DFI | Director of Finance/CFO | 66 | 17-11-13 |
Victoria Bantz
LAW | General Counsel | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Clarence Smith
CEO | Chief Executive Officer | 60 | 14-05-31 |
Edward McDonough
BRD | Director/Board Member | 71 | 15-06-30 |
1st Jan change | Capi. | |
---|---|---|
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |